Sources: Reuters
The Butantan Institute opens a factory that will develop more products of China’s CoronaVac COVID-19 vaccine beginning in 2023. 2022-03-25
Cambodia begins a COVID-19 vaccination rollout for children over the age of 6 using the Chinese-made Sinovac CoronaVac vaccine. 2021-09-17
China becomes the first major country to authorize the emergency use of the Sinovac CoronaVac vaccine for children as young as three years old. 2021-06-5
Sri Lanka receives 600,000 doses of the Sinopharm BBIBP-CorV vaccine from China. Vaccination of Chinese nationals could commence first as the Medicines Regulatory Authority says that the vaccination of Sri Lankans will begin after a study by a committee of experts. 2021-03-31
Mauritania begins a vaccination campaign against COVID-19 after receiving 500,000 doses of the Sinovac CoronaVac vaccine from China. 2021-03-26
Pakistan approves the emergency use of China's CanSinoBio vaccine, becoming the fourth vaccine to be approved in the country. 2021-02-12
China's National Medical Products Administration gives a conditional approval to Sinovac's Coronavac vaccine for general use. 2021-02-6
Mexican Foreign Minister Marcelo Ebrard announces the country has signed agreements with AstraZeneca for 77.4 million, COVAX for 51.57 million, CanSino Biologics for 35 million, and Pfizer for 34.4 million vaccine doses, respectively. The vaccines by Pfizer, AstraZeneca, and the COVAX plan require two doses, whereas the CanSino product requires one dose. 2020-10-13
Mexico announces that it will pay $159.88 million to the World Health Organization to secure vaccine access through the agency’s COVAX plan. 2020-10-10